Table 1.
Baseline patient and study characteristics.
| Study/Year/Country | Study type | N | Mean Age years | Male (%) |
DM (%) |
HTN (%) |
Dyslipid -emia (%) |
Smoking (%) |
PAD (%) |
Hx of CABG (%) |
Hx of MI (%) |
Hx of PCI | CKD (%) |
mean LVEF | STEMI (%) |
NSTEMI (%) |
UA (%) |
Stable CAD (%) |
Dialysis (%) |
Lesion length(mm), mean | Ostial lesion (%) |
Bifurcation lesion (%) |
type of vessel (%) |
Burr Size (mm) |
Elective RA (%) |
Bailout RA (%) |
Vessels involved (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elbasha K et al., 2022 Germany | Single center Retrospective study | 812 | 72.5 | 80 | 40 | 92.5 | 64.8 | 30 | N/A | 20 | 21.3 | 48.8 | 8.8 | 49.6 | 2.5 | 6.3 | 7.5 | 73.8 | 2.5 | 41.6 | 13.8 | 25 | CAD one 10 CAD two 21.3 CAD three 68.8 |
1.38 | 38.7 | 61.3 | LM 0 LAD 28.7 LCx 8.8 RCA 62.5 |
| Brinkmann C et al., 2018 Germany | Single center Retrospective study | 392 | 69.5 | 86.7 | 32 | 78.7 | 68 | N/A | 17.3 | 32 | 24 | 69.3 | N/A | 55 | N/A | N/A | N/A | N/A | N/A | 45.2 | N/A | N/A | CAD one 22.7 CAD two 18.7 CAD three 58.7 |
1.49 | N/A | N/A | LM 0 LAD 12 LCx 18.7 RCA 69.3 |
| Tsai T-C et al., 2022 Taiwan | Single center Retrospective study | 81 | 71.6 | 75 | 45.5 | 70.5 | N/A | N/A | 4.5 | 2.3 | N/A | N/A | N/A | 43.5 | 13.6 | 15.9 | 38.6 | N/A | N/A | N/A | 38.6 | 18.2 | CAD one 34.1 CAD two 20.5 CAD three 34.1 |
N/A | N/A | N/A | LM 11.4 LAD 47.7 LCx 9.1 RCA 27.3 |
| Lee SN et al., 2021 Korea | Multicenter Retrospective study | 583 | 63.9 | 83.3 | 61.9 | 76.2 | 50 | 23.8 | N/A | 11.9 | 14.3 | 40.5 | 21.4 | 52 | 9.5 | 7.1 | 9.5 | N/A | N/A | N/A | N/A | N/A | CAD one N/A CAD two N/A CAD three 85.7 |
N/A | N/A | N/A | LM 11.9 LAD N/A LCx N/A RCA N/A |
Note: PAD: Peripheral arterial disease; CAD: Coronary artery disease; RCA: Right coronary artery; CABG: Coronary artery bypass grafting; LM: Left main artery; N/A: Not reported.